Apr 22, 2019 1:40pm
Two excellent review articles appear in the March entry of the online journal, Clinical Laboratory Science. They are:
Apr 22, 2019 1:02pm
I've attached a pre-pub article describing a phase I trial of ACT017, a novel antiplatelet antibody fragment specific for glycoprotein VI, a platelet membrane collagen receptor. The manufacturers propose that ACT017 infusion can suppress platelet activity as part of coronary artery disease therapy with minimal bleeding risk. Clip or tap the citation for full information:
Apr 16, 2019 9:11am
Poor old aspirin has again lost ground. Here's an editorial from the January, 2019 issue of European Heart Journal describing a meta-analysis of aspirin's lack of efficacy in subjects who have no cardiovascular disease risk factors:
Apr 9, 2019 4:49pm
George received this question for our quality assurance experts. When validating a procedure, do you work with a single lot or multiple lots?  
1 Comment